Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1991-06-05
1998-08-04
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
5142315, 514255, 514314, 514326, 514336, 514422, 514475, 544 59, 544162, 544170, 544374, 546153, 546220, 546269, 548517, 549332, A61K 3154, C07D27912, C07D21516, C07D30304
Patent
active
057894051
ABSTRACT:
##STR1## useful in inhibiting angiogenesis in solid tumors.
REFERENCES:
Chemical Abstracts, vol. 106, No. 23, Jun. 8, 1987, Columbus, Ohio, USA, Fujisawa Pharmaceutical Co. "Immunosuppressent manufacture by Penicillium species", p. 604, col. 2, Abstract No. 194 770b.
Chemical Abstracts, vol. 106, No. 21, May 25, 1987, Columbus, Ohio, USA; Fujisawa Pharmaceutical Co. "Oxaspirooctane compounds as immunosuppressants" p. 706, col. 2, Abstract No. 176 153y.
Chemical Abstracts, vol. 105, No. 7, Aug. 18, 1986, Columbus, Ohio, USA; Fujisawa Pharmaceutical Co. "Manufacture of immuno-suppressive FR-65814 with Penicillium jensenii" p. 515, col. 2, abstract No. 59 452p.
Tarbell, D S et al "The Structure of Fumagillin" JACS Communications to the Editor vol. 82 pp. 1005-1011 (1960).
Hashimoto Masashi
Kasahara Chiyoshi
Ohkawa Takehiko
Oku Teruo
Fujisawa Pharmaceutical Co. Ltd.
Ivy C. Warren
Solola Taofiq A.
LandOfFree
Oxaspiro(2,5)octane derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oxaspiro(2,5)octane derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxaspiro(2,5)octane derivative will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1177400